![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 16, 13650-13658, April 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of The Heparin (Hep) II-binding domain of
fibronectin regulates the formation of focal adhesions and actin stress
fibers and hence plays an important role in cell spreading, migration,
and fibronectin fibrillogenesis. Using human skin fibroblast cultures, we demonstrate that alternative splicing of the neighboring IIICS domain may regulate the activities of the Hep II domain in cell spreading and fibronectin fibrillogenesis. Recombinant Hep II domains,
adjacent to either the IIICS domain or the H89 splice variant that
contains the amino-terminal sequence of the IIICS domain, blocked
fibronectin fibrillogenesis and required sulfated proteoglycans to
mediate cell spreading. If the Hep II domain was adjacent to either the
H0 or H95 splice variants, which both lack the amino terminus of the
IIICS domain, fibrillogenesis was not inhibited and cell spreading was
independent of a sulfated proteoglycan-mediated mechanism. The effect
of the splice variants on the Hep II domain could be mimicked using a
Hep II domain that contained only 6 amino acids from the
III15 repeat or 10 amino acids from the IIICS domain
suggesting that sequences proximal to the III14 repeat
determined the role of the Hep II domain in these processes. We propose
that alternative splicing of the IIICS domain modulates interactions
between heparan sulfate proteoglycans and the Hep II domain and that
this serves as a mechanism to control the biological activities of fibronectin.
Alternative Splicing of the IIICS Domain in Fibronectin
Governs the Role of the Heparin II Domain in Fibrillogenesis
and Cell Spreading*
§,
,
,
**
Pathology and Laboratory
Medicine and
Ophthalmology and Visual Sciences, University of
Wisconsin, Madison, Wisconsin 53706 and the ¶ Wellcome Trust
Centre for Cell-Matrix Research, School of Biological Sciences,
University of Manchester,
M13 9PT Manchester, United Kingdom
*
This work was supported in part by National Institutes of
Health Grant EY12515, the American Heart Association grant-in-aid, Wisconsin Affiliate, National Science Foundation Grant MCB9728382 (to
D. M. P.), and the Wellcome Trust (to M. J. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
K. E. Keller, J. M. Bradley, M. J. Kelley, and T. S. Acott Effects of Modifiers of Glycosaminoglycan Biosynthesis on Outflow Facility in Perfusion Culture Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2495 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Castelletti, R. Donadelli, F. Banterla, F. Hildebrandt, P. F. Zipfel, E. Bresin, E. Otto, C. Skerka, A. Renieri, M. Todeschini, et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits PNAS, February 19, 2008; 105(7): 2538 - 2543. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Filla, A. Woods, P. L. Kaufman, and D. M. Peters {beta}1 and {beta}3 Integrins Cooperate to Induce Syndecan-4-Containing Cross-linked Actin Networks in Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1956 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vittal, A. Rose, K. E. Gregory, M. J. Kelley, and T. S. Acott Changes in Gene Expression by Trabecular Meshwork Cells in Response to Mechanical Stretching Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2857 - 2868. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Peterson, N. Sheibani, G. David, A. Garcia-Pardo, and D. M. Peters Heparin II Domain of Fibronectin Uses {alpha}4{beta}1 Integrin to Control Focal Adhesion and Stress Fiber Formation, Independent of Syndecan-4 J. Biol. Chem., February 25, 2005; 280(8): 6915 - 6922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Santas, C. Bahler, J. A. Peterson, M. S. Filla, P. L. Kaufman, E. R. Tamm, D. H. Johnson, and D. M. P. Peters Effect of Heparin II Domain of Fibronectin on Aqueous Outflow in Cultured Anterior Segments of Human Eyes Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4796 - 4804. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gendelman, N. I. Burton-Wurster, J. N. MacLeod, and G. Lust The Cartilage-specific Fibronectin Isoform Has a High Affinity Binding Site for the Small Proteoglycan Decorin J. Biol. Chem., March 21, 2003; 278(13): 11175 - 11181. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |